Antigen recognition by CD1d-restricted NKT T cell receptors

被引:87
作者
Godfrey, Dale I. [1 ]
Pellicci, Daniel G. [1 ]
Patel, Onisha [2 ]
Kjer-Nielsen, Lars [1 ]
McCluskey, James [1 ]
Rossjohn, Jamie [2 ]
机构
[1] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[2] Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
NKT cells; CD1d; T cell receptor; Glycolipids; CRYSTAL-STRUCTURE; MOUSE CD1D; ALPHA-GALACTOSYLCERAMIDE; IMMUNOREGULATORY AXIS; STRUCTURAL BASIS; TUMOR-IMMUNITY; IN-VIVO; COMPLEX; SELECTION; BINDING;
D O I
10.1016/j.smim.2009.10.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
alpha beta T cell receptors (TCRs) have traditionally been viewed as receptors for peptide antigens presented by either Major Histocompatibility Complex (MHC) class I (for CD8 T cells) or MHC class II (for CD4 T cells) antigen-presenting molecules. However, it is now clear that some T cell lineages express TCRs that are specialized for recognition of lipid-based antigens presented by the MHC class I-like CD1 family. Recently, the molecular basis for the TCR recognition of glycolipid antigens presented by CD1d has revealed an evolutionarily conserved-docking mode that is distinct from that of peptide-based recognition. T cells carrying these receptors follow a unique developmental pathway that results not only in unconventional antigen specificity, but also seemingly exaggerated functional capabilities, which makes these cells and their antigens highly attractive targets for immunotherapeutic manipulation. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 71 条
[1]   Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis [J].
Ambrosino, Elena ;
Terabe, Masaki ;
Halder, Ramesh C. ;
Peng, Judy ;
Takaku, Shun ;
Miyake, Sachiko ;
Yamamura, Takashi ;
Kumar, Vipin ;
Berzofsky, Jay A. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (08) :5126-5136
[2]   Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition [J].
Archbold, Julia K. ;
Macdonald, Whitney A. ;
Gras, Stephanie ;
Ely, Lauren K. ;
Miles, John J. ;
Bell, Melissa J. ;
Brennan, Rebekah M. ;
Beddoe, Travis ;
Wilce, Matthew C. J. ;
Clements, Craig S. ;
Purcell, Anthony W. ;
McCluskey, James ;
Burrows, Scott R. ;
Rossjohn, Jamie .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (01) :209-219
[3]   CD1 antigen presentation: how it works [J].
Barral, Duarte C. ;
Brenner, Michael B. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (12) :929-941
[4]   Characterization of the early stages of thymic NKT cell development [J].
Benlagha, K ;
Wei, DG ;
Veiga, J ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) :485-492
[5]  
Borg NA, 2007, ADV EXP MED BIOL, V598, P20
[6]   CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor [J].
Borg, Natalie A. ;
Wun, Kwok S. ;
Kjer-Nielsen, Lars ;
Wilce, Matthew C. J. ;
Pellicci, Daniel G. ;
Koh, Ruide ;
Besra, Gurdyal S. ;
Bharadwaj, Mandvi ;
Godfrey, Dale I. ;
McCluskey, James ;
Rossjohn, Jamie .
NATURE, 2007, 448 (7149) :44-49
[7]   Signaling for NKT cell development: the SAP-FynT connection [J].
Borowski, C ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (06) :833-836
[8]   CD1: Antigen presentation and T cell function [J].
Brigl, M ;
Brenner, MB .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :817-890
[9]   CD1-RESTRICTED CD4(+) T-CELLS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-DEFICIENT MICE [J].
CARDELL, S ;
TANGRI, S ;
CHAN, S ;
KRONENBERG, M ;
BENOIST, C ;
MATHIS, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :993-1004
[10]   Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer [J].
Chang, David H. ;
Deng, Haiteng ;
Matthews, Phillip ;
Krasovsky, Joseph ;
Ragupathi, Govind ;
Spisek, Radek ;
Mazumder, Amitabha ;
Vesole, David H. ;
Jagannath, Sundar ;
Dhodapkar, Madhav V. .
BLOOD, 2008, 112 (04) :1308-1316